檢索目的: 對羥基苯甲酸甲酯(Methylparaben) 的生物活性測試相關文獻 檢索方式: 任意數據庫 化合物CA登記號(CAS): 未知   [更多]

1.文章名稱： 1).Six-Month Response to Delamanid Treatment in MDR TB Patients.C Hewison, G Ferlazzo, Z Avaliani.2017. 2).Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. Acta Pharm Nord. 1992;4(3):149-58. 3) Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary XDR-TB 2.需要下載到文獻全文的PDF版本，以文獻原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得20元獎勵   [更多]

1.文章名稱： (1).Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Kawate H, Takayanagi R.Clin Interv Aging. 2011;6:151-60. Epub 2011 Jun 21. Review. (2).J Vasc Surg. 2017 May 19. pii: S0741-5214(17)30915-1. Medical management of claudication. Ratchford EV. (3). Neuropsychiatr Dis Treat. 2017 May 11;13:1281-1302. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Kishi T, Ikuta T, Matsunaga S, Matsuda Y1,, Oya K, Iwata N. (4). BMJ Case Rep. 2017 May 9;2017. pii: bcr-2017-219929. Aripiprazole-induced hypersensitivity pneumonitis. Gunasekaran K, Murthi S, Jennings J, Lone N. (5). Curr Neuropharmacol. 2017 Apr 13. Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity. Tuplin EW1, Holahan MR. (6). Expert Opin Pharmacother. 2017 Feb;18(2):217-223. Brexpiprazole for the treatment of schizophrenia. Hsu WY, Lane HY, Lin CH. (7). J Clin Psychiatry. 2015 Sep;76(9):1232-40. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study. Thase ME1, Youakim JM, Skuban A, Hobart M, Zhang P, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H. (8). Ter Arkh. 2017;89(4):101-109. New opportunities for the prevention of gastric cancer. Maev IG, Kazyulin AN. (9). Oral Dis. 2017 May;23(4):511-517. Rebamipide, an anti-ulcerative drug, inhibits induction of salivary dysfunction by benzodiazepines. Ogane M, Okubo M, Yoshikawa M, Shinomiya T, Tsukagoshi E, Kawaguchi M. (10).、Int J Clin Pharm. 2017 May 29.Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.Huang JJ, Chen B, Hu J. 2.需要下載到文獻全文的PDF版本，以文獻原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎勵   [更多]

要求： 1.國家批準的，在保護期內的265個中藥保護品種； 2.其2016年的銷售數據； 3.數據需準確。   [更多]

低價尋求一份依魯替尼研究報告，希望內容詳盡   [更多]

重金懸賞一份藥企“母公司-子公司”文件，需用EXCEL列出各藥企母公司以及所有子公司名稱。確保信息準確。   [更多]

1.文章名稱： （1）Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.M. Biswas (1), G. L. Rogers (1), A. Sherman (1), B. J. Byrne (1), D. M. Markusic (1), H. Jiang (2), R. W. Herzog (1).University of Florida, Department of Pediatrics, Division of Cellular and Molecular Therapy, Gainesville, Florida, USA; (2) Biogen, Cambridge, Massachusetts, USA. 2.需要下載到文獻全文的PDF版本，以文獻原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎勵   [更多]

1.文章名稱： （1）A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. Scharf, Martin B.; Roth, Thomas; Vogel, Gerald W.; Walsh, James K.The Journal of Clinical Psychiatry, Vol 55(5), May 1994, 192-199. （2）Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep: Journal of Sleep Research & Sleep Medicine, Vol 22(Suppl 2), May 1999, S354-S358. 2.需要下載到文獻全文的PDF版本，以文獻原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎勵   [更多]

1. 1,1-Cyclobutanedicarboxylic acid 急性毒性試驗半數致死量（LD50） 2. 1,1-Cyclobutanedicarboxylic acid 亞慢性毒性試驗半數致死量（LD50） 3. 1,1-Cyclobutanedicarboxylic acid 慢性毒性試驗半數致死量（LD50）   [更多]

查詢15，16年中國銷售利潤超過500萬的農藥企業銷售名單 以及數據（參照農藥工業協會名單）。 如果能精確到主要產品 可以商量價格   [更多]